Are you Dr. Uhl?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 54 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5555 Grossmont Center Dr
La Mesa, CA 91942Phone+1 619-644-4500Fax+1 619-644-4547
Summary
- Dr. Barry Uhl, MD is a radiation oncologist in La Mesa, California. He is currently licensed to practice medicine in California. He is affiliated with Sharp Grossmont Hospital, Sharp Memorial Hospital, and Sharp Chula Vista Medical Center.
Education & Training
- Baylor College of MedicineResidency, Radiation Oncology, 1996 - 2000
- University of Nebraska Medical Center College of MedicineInternship, Internal Medicine, 1995 - 1996
- University of Nebraska College of MedicineClass of 1995
Certifications & Licensure
- CA State Medical License 2000 - 2026
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Clinical Trials
- Stereotactic Hypofractionated Radiosurgery for Early Stage Prostate Cancer Start of enrollment: 2009 Aug 01
Publications & Presentations
PubMed
- 139 citationsIntensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis.Bin S. Teh, Wei Yuan Mai, Barry M. Uhl, Mark E. Augspurger, Walter H. Grant
International Journal of Radiation Oncology, Biology, Physics. 2001-03-01 - 223 citationsSMART (Simultaneous Modulated Accelerated Radiation Therapy) boost: A new accelerated fractionation schedule for the treatment of head and neck cancer with intensity m...E. Brian Butler, Bin S. Teh, Walter H. Grant, Barry M. Uhl, Ronald B. Kuppersmith
International Journal of Radiation Oncology, Biology, Physics. 1999-08-01 - 74 citationsIntensity modulated radiation therapy (IMRT) following prostatectomy: more favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancerBin S. Teh, Wei Yuan Mai, Mark E. Augspurger, Barry M. Uhl, John E. McGary
International Journal of Radiation Oncology, Biology, Physics. 2001-02-01